Elanco Animal Health (ELAN) Other Non-Current Assets (2017 - 2026)

Elanco Animal Health's (ELAN) quarterly Other Non-Current Assets came in at $295.0 million in Q1 2026, down 5.45% year-on-year from $312.0 million in Q1 2025, and down 2.96% quarter-over-quarter from $304.0 million in Q4 2025.

Elanco Animal Health (ELAN) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Elanco Animal Health has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $295.0 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $295.0 million, down 5.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $295.0 million (down 5.45% YoY), and the FY2025 annual result was $304.0 million, down 2.25% from the prior year.
  • Other Non-Current Assets came in at $295.0 million for Q1 2026 at Elanco Animal Health, down from $304.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $651.0 million in Q1 2024 to a low of $295.0 million in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $369.0 million (2023), against an average of $390.8 million.
  • Across the five-year window, Other Non-Current Assets jumped 76.42% in 2024 and sank 52.07% in 2025, its largest moves.
  • Elanco Animal Health's Other Non-Current Assets stood at $378.0 million in 2022, then decreased by 9.79% to $341.0 million in 2023, then slipped by 8.8% to $311.0 million in 2024, then declined by 2.25% to $304.0 million in 2025, then slipped by 2.96% to $295.0 million in 2026.
  • The last three Other Non-Current Assets figures came in at $295.0 million (Q1 2026), $304.0 million (Q4 2025), and $306.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.79 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 59.36 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 47.63 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 3.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 295.00 Mn
Dec 31, 2025 304.00 Mn
Sep 30, 2025 306.00 Mn
Jun 30, 2025 308.00 Mn
Mar 31, 2025 312.00 Mn
Dec 31, 2024 311.00 Mn
Sep 30, 2024 302.00 Mn
Jun 30, 2024 627.00 Mn
Mar 31, 2024 651.00 Mn
Dec 31, 2023 341.00 Mn
Sep 30, 2023 410.00 Mn
Jun 30, 2023 419.00 Mn
Mar 31, 2023 369.00 Mn
Dec 31, 2022 378.00 Mn
Sep 30, 2022 376.00 Mn
Jun 30, 2022 376.00 Mn
Mar 31, 2022 559.00 Mn
Dec 31, 2021 390.00 Mn
Sep 30, 2021 357.00 Mn
Jun 30, 2021 375.00 Mn